FLXN Horizon Flexible Income ETF
24.70USD+0.28%Mkt Cap: —P/E: 24.597d ago
The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund’s Fixed Income Instruments may include debt or debt-rel…
Industry Peers
Drug Manufacturers - General$1.04TUSDP/E 39.3
$618.09BUSDP/E 29.7
$481.40BUSDP/E 77.0
$351.28BUSDP/E 113.0
$328.28BUSDP/E 23.5
$320.73BUSDP/E 23.0
ROG
Roche Holding AG$329.23BUSDP/E 21.2
$272.01BUSDP/E 21.6
$255.37BUSDP/E 22.4
$260.71BUSDP/E 25.2
$246.25BUSDP/E 23.7
$233.57BUSDP/E 25.1
$220.28BUSDP/E 25.3
$200.47BUSDP/E 23.8
$182.40BUSD
$168.54BUSDP/E 9.3
$158.56BUSDP/E 36.6
$121.70BUSDP/E 13.1
$96.40BUSDP/E 21.2
$92.37BUSDP/E 21.8
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price24.70 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)24.59
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
24.5112% of range26.09
52W High26.09 USD
52W Low24.51 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield9.59%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 5024.68 (+0.1%)
SMA 20025.14 (-1.8%)
Beta—
S&P 52W Chg—
Avg Vol (30d)9.37K
Avg Vol (10d)25.94K
Technical Indicators
RSI (14)23.9
MACD-0.1968
MACD Signal-0.1436
MACD Hist.-0.0532
BB Upper25.01 USD
BB Middle24.47 USD
BB Lower23.92 USD
BB Width4.43%
ATR (14)0.1177 USD
Vol Ratio (20d)0.88x